Tenderwize
Back to tender search

Open-House Original Discount Agreements 2026-03 - Dolutegravir/Rilpivirin (Active Ingredient Combination)

Techniker Krankenkasse·Hamburg, Germany·Deadline May 31, 2028 · 652 days left·Open·Supplies
Sign up to saveOpen documents
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open-House-Originale-Rabattverträge 2026-03 - Dolutegravir/Rilpivirin (Wirkstoffkombination)

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

No estimated contract value or minimum volume guaranteed; actual revenue dependent on prescriptions.

Contract ends automatically upon patent expiry or loss of market exclusivity before the scheduled end date.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2028
  • Pharmaceutical discount agreements for Dolutegravir/Rilpivirin combination.
  • Open-House procedure with no negotiation, standard conditions.
Show full summary

Open-House procedure for concluding pharmaceutical discount agreements for Dolutegravir/Rilpivirin combination under §130c SGB V. No estimated value provided. Continuous enrollment possible until 31 May 2028.

Risks

No estimated contract value or minimum volume guaranteed; actual revenue dependent on prescriptions.

Contract ends automatically upon patent expiry or loss of market exclusivity before the scheduled end date.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as defined in §4 Abs. 18 AMG.
  • Must hold a valid marketing authorization for the medicinal product.
  • Must have seat in Germany, EU, or EEA.

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria specified; selection is based on eligibility.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-House Original Discount Agreements 2026-03 - Dolutegravir/Rilpivirin (Active Ingredient Combination)

Conclusion of pharmaceutical discount agreements for Dolutegravir/Rilpivirin combination.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

May 2026 - May 2028

Category

Pharmaceutical products

Award Criteria

No award criteria specified; selection is based on eligibility.

Deadline

Deadline May 31, 2028

Procurement Details

Publication date
23 Apr 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
281148-2026

Documents (1)

Procurement document 1

Similar tenders

Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)

Sep 15
1 SME lot

Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów

Sep 17

France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord

Sep 14
6 SME lots

Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)

Aug 27
3 framework lots3 SME lots

Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ

Sep 18

Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).

Sep 24